| INTRODUC TI ON
Avian influenza viruses (AIV) belong to type A influenza virus, whose genome consists of eight segments of single-stranded RNA. The segments 4 and 6 encode two surface proteins, the hemagglutinin (HA) and neuraminidase (NA), which could subtype AIVs into H1-H16 and N1-N9, respectively. Other six segments encode the viral internal genes: polymerase basic protein 2 (PB2, segment 1), polymerase basic protein 1 (PB1, segment 2), polymerase acidic protein (PA, segment 3), nucleocapsid protein (NP, segment 5), the matrix proteins (MP, segment 7), and the nonstructural proteins (NS, segment 8). Reassortment of segments originated from different hosts may facilitate virus cross-species transmission.
Since 2013, the three original reassortment low pathogenic avian influenza (LPAI) A(H7N9) viruses have emerged and caused five epidemic waves with over 1500 human cases in China. 1 In early 2017, human infections with a highly pathogenic avian influenza (HPAI)
A(H7N9) virus were reported in Taiwan and Guangdong Provinces of China. 2, 3 Phylogenic analyses showed that the HPAI H7N9 virus originated from the LPAI H7N9 virus. 4, 5 The signature genetic difference between HPAI and LPAI H7N9 virus was an insertion of four amino acids at the cleavage site of the HA protein. 3, 6 Biological assays both in vitro and in vivo indicated that this insertion caused a switch in the virulence of the H7N9 virus in poultry. [6] [7] [8] To date, most evidence supports the notion that the insertion event probably occurred in poultry in the Pearl River Delta region and that the Guangdong Province was the original location of the HPAI H7N9
virus. 4, 5 The HPAI H7N9 virus might have emerged in mid-2016, according to a molecular clock model. 4, 5 
| MATERIAL S AND ME THODS

| Ethics statement
As a public health response to the outbreak, written informed consent of the study subjects could be waived according to Chinese law. 
| Clinical and epidemiologic data collection
The clinical history and epidemiologic information were obtained from epidemiological investigation reports, conducted by local centers for disease control and prevention.
| Sample collection and isolation
Respiratory specimens from patients and environmental samples including swabs of cages, feces, chopping boards, sewage, and poultry drinking water from live poultry markets or farms were collected by local centers for disease control and prevention, according to the national influenza surveillance guidelines. Each sample was collected in individual vials, placed in transport medium with antibiotics, and packed on ice before it was sent to the laboratory for further processing. a coverage depth of at least 100 times at each site on the eight segments. The sequences generated in this study were submitted to the GISAID database (accession number: EPI1252096-EPI1252159).
| Sequencing
| Phylogenetic analysis
The 
| RE SULTS
| The patient
The patient was a 59-year-old man with diabetes who raised about 
| Environmental surveillance
The environmental surveillance on live poultry markets and poultry Seven H7 viruses were isolated from the H7-positive samples.
After sequencing, one of them was identified as an LPAI H7N9 virus and six were identified as HPAI H7 viruses including five H7N9 viruses and one H7N6 virus (Table 1) . These HPAI H7 viruses were from four surveillance sites and were all collected after August 2017 ( Figure 1 and Table 1 ).
| Molecular markers
As shown in Table 1 , all HPAI H7 viruses contained a 4-amino-acid insertion ("KRTA" or "KRAA") in the HA cleavage site. The LPAI A/ Environment/Fujian/24907/2017(H7N9) virus encoded amino acid residues 186V and 226L (H3 numbering) in the HA protein, while all the HPAI viruses contained 186V and 226Q. Both combinations could recognize avian-and human-type receptors. 7, 11, 12 Table 2 ). The human isolate contained seven mutations including R22K, R47K, G133E, K163R, I169V, R252K, and R261G (H7 HA1 numbering without signal peptide). In these mutations, R47K and G133E have been reported to be resistant to the neutralizing activity of monoclonal antibodies from H7N9-immunized mouse. 17 And one and five environmental isolates also have R47K and G133E mutations, respectively. and NS (69.9-99.8%).
| Genetic diversity of H7 viruses
| Origins of eight segments of HPAI H7 viruses
To identify the origins of the genetic diversity, phylogenetic analyses were conducted for all eight segments with sequences from the GISAID EpiFlu™ database, which have a higher similarity with viruses In Fujian Province, all the isolates from human cases were LPAI H7N9 viruses before mid-2017, according to the available sequences.
| D ISCUSS I ON
In the present study, we reported a human case infected with an China, spread to South Korea and Japan, and other continents by migratory birds. 21 The new genotype viruses still carried the HA 186V residue, which indicate its dual receptor binding property. And the mammalian-adapted mutation PB2 701N was found in the human isolates. In addition, they contained several HA1 mutations to the HPAI H7N9 candidate vaccine virus, which could affect the HA antigenicity. Since September 2017, H5/H7 bivalent vaccination was adopted as a major control strategy in poultry in Mainland China.
Antigenic drift of H7N9 virus could increase the possibility of H7 vaccine escapes in the near future, which is an additional risk for re-emergence of H7N9 virus.
Our findings suggest that the HPAI H7 virus could have derived its genetic diversity from extensive avian influenza viruses and an expanded host range, possessing a risk to public health and animal health. Although no human to human transmission was detected, considering their ability to cause severe illness in humans and domestic birds, the sustained close surveillance of HPAI H7 viruses with novel genotypes is essential. 
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